Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infectio
- Conditions
- Herpes SimplexTherapeutic area: Diseases [C] - Virus Diseases [C02]
- Registration Number
- EUCTR2015-004441-17-Outside-EU/EEA
- Lead Sponsor
- ovartis Pharmaceuticals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- A
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
•History or laboratory evidence of herpes simplex infection
•Clinical evidence or suspicion of herpes simplex infection
Are the trial subjects under 18? yes
Number of subjects for this age range: 74
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
•Patients unable to swallow
•Concomitant use of probenecid
•Positive pregnancy test
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method